BioLineRx Ltd (BLRX)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -35.108 | -48.751 | -39.185 | -46.35 | -59.532 | -42.048 | -31.629 | -86.401 |
Return on Equity (%) | -38.339 | -55.403 | -48.751 | -68.128 | -108.36 | -60.042 | -41.96 | -189.23 |
Return on Invested Capital (%) | -39.665 | -57.79 | -50.477 | -63.487 | -71.476 | -53.344 | -45.711 | -108.426 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -1218.125 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -1262.792 |
Book Value Per Share | 0.611 | 0.436 | 0.168 | 0.067 | 0.001 | 0.065 | 0.031 | -0.002 |
Earnings Per Share | -0.278 | -0.232 | -0.2 | -0.149 | -0.086 | -0.038 | -0.027 | -0.056 |
Cash Per Share | 0.043 | 0.049 | 0.03 | 0.031 | 0.048 | 0.018 | 0.011 | 0.004 |
Working Capital Per Share | 0.569 | 0.416 | 0.219 | 0.095 | 0.035 | 0.067 | 0.045 | 0.015 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.001 |
EBIT Per Share | -0.278 | -0.232 | -0.2 | -0.149 | -0.086 | -0.038 | -0.027 | -0.056 |
EBITDA Per Share | -0.278 | -0.232 | -0.2 | -0.149 | -0.086 | -0.038 | -0.027 | -0.056 |
Free Cash Flow Per Share | -0.285 | -0.196 | -0.116 | -0.151 | -0.088 | -0.038 | -0.027 | -0.056 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | 3.399 | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -10.153 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 18.66M |
Price to Earnings Ratio | 0 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 79.94M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.